Ultragenyx Pharmaceutical Inc logo

Ultragenyx Pharmaceutical Inc

NEW
LTS:0LIF (USA)  
$ 13.87 -0.47 (-3.28%) Sep 14
At Loss
Market Cap:
$ 1.34B
Enterprise V:
$ 705.29M
Volume:
23.96K
Avg Vol (2M):
17.43K
Trade In:
Volume:
23.96K
At Loss
Avg Vol (2M):
17.43K

Ultragenyx Pharmaceutical Inc (LTS:0LIF) Dividend

Ultragenyx Pharmaceutical Inc (LTS:0LIF) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -11.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0LIF Dividend

Does Ultragenyx Pharmaceutical Inc (LTS:0LIF) pay a dividend?

Ultragenyx Pharmaceutical Inc (LTS:0LIF) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Ultragenyx Pharmaceutical Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Ultragenyx Pharmaceutical Inc has returned capital to shareholders via buybacks at a rate of -11.2% over the past 3 years.

What are dividend-paying alternatives to Ultragenyx Pharmaceutical Inc?

For dividend-paying alternatives in Ultragenyx Pharmaceutical Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.